Outcome of surgical treatment for acromegaly performed by a single neurosurgeon and cumulative meta-analysis;Resultados do tratamento cirúrgico na acromegalia com um único neurocirurgião e meta-análise cumulativa

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 50, Issue 5, 2006, Pages 884-892

  Boeving, Anke ^a   Borba, Luiz Alencar ^a   Rodrigues, Adriane Maria ^a   Orichowski, Elisa Brunner ^a   Filho, Gilberto Jorge Da Paz ^a   Dos Santos, Carlos M Correa ^a   Boguszewski, César Luiz ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Acromegaly; Growth hormone; Neurosurgery; Pituitary neoplasms; Therapeutics

Indexed keywords

BIOLOGICAL MARKER; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADENOMA; ADULT; AGED; ARTICLE; BLOOD; CANCER INVASION; CLINICAL TRIAL; EPIDEMIOLOGY; EVALUATION; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE SECRETING ADENOMA; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; NEUROSURGERY; PATHOLOGY; REMISSION; SECRETION; SPHENOID; STANDARD; TREATMENT OUTCOME;

ACROMEGALY; ADENOMA; ADULT; AGED; BIOLOGICAL MARKERS; EPIDEMIOLOGIC METHODS; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEUROSURGICAL PROCEDURES; REMISSION INDUCTION; SPHENOID BONE; TREATMENT OUTCOME;

EID: 33845787884     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302006000500009     Document Type: Article

References (29)

1. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, et al. Criteria for Cure of Acromegaly: a consensus statement. J Clin Endocrinol Metab 2000;85:526-9.
2. Growth Hormone Research Society, Pituitary Society. Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a Joint Consensus Conference of The Growth Hormone Research Society and The Pituitary Society. J Clin Endocrinol Metab 2004;89:3099-102.
3. Cook DM, Ezzat S, Katznelson L, Kleinberg DL, Laws ER, Nippoldt TB, et al. American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly. Endocr Pract 2004;10:213-25.
4. Gittoes NJL, Sheppard MC, Johnson AP, Stewart PM. Outcome of surgery for acromegaly - the experience of a dedicated pituitary surgeon. Q J Med 1999;92:741-5.
5. Ciric I, Ragin A, Baumgartner C, Pierce D. Complications of transsphenoidal surgery: results of a national survey, review of literature, and personal experience. Neurosurgery 1997;40:225-36.
6. Gillberg P, Bramnert M, Thoren M, Werner S, Johannsson G. Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function. Growth Horm IGF Res 2001;11:273-81.
7. Ronchi CL, Varca V, Giavoli C, Epaminonda P, Beck-Peccoz P, Spada A, et al. Long-term evaluation of postoperative acromegalic patients in remission with previous and newly proposed criteria. J Clin Endocrinol Metab 2005;90:1377-82.
8. Sheaves R, Jenkins P, Blackburn P, Huneidi AH, Afshar F, Medbak S, et al. Outcome of transsphenoidal surgery for acromegaly using criteria for surgical cure. Clin Endocrinol (Oxf) 1996;45:407-13.
9. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 1998;83:3411-8.
10. Swearingen B, Barker II FG, Katznelson L, Biller BMK, Grinspoon S, Klibanski A, et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998;83:3419-26.
11. Ahmed S, Elsheikh M, Stratton IM, Page RCL, Adams CBT, Wass JAH. Outcome of transsphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol (Oxf) 1999;50:561-7.
12. Kreutzer J, Vance ML, Lopes MBS, Laws ER. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 2001;86:4072-7.
13. Beauregard C, Truong U, Hardy J, Serri O. Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol (Oxf) 2003;58:86-91.
14. Biermasz NR, Dekker FW, Pereira AM, Van Thiel SW, Schutte PJ, Van Dulken H, et al. Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. J Clin Endocrinol Metab 2004;89:2789-96.
15. Serri O, Beauregard C, Hardy J. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly. J Clin Endocrinol Metab 2004;89:658-61.
16. Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical "cure". Eur J Endocrinol 2005;152:379-87.
17. Kauppinen-Mäkelin R, Sane T, Reunanen A, Välimäki MJ, Niskanen L, Markkanen H, et al. A nationwide survey of mortality in acromegaly. J Clin Endocrinol Metab 2005;90:4081-6.
18. Boguszewski CL. O laboratório no diagnóstico e seguimento da acromegalia. Arq Bras Endocrinol Metab 2002;46:34-44.
19. Damjanovic S, Neskovict A, Petakov M, Popovic V, Joksimovic M. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure? Clin Endocrinol (Oxf) 2005;62:410-7.
20. Bates AS, Van't Hoff W, James JM, Clayton RN. An audit of outcome of treatment in acromegaly. Q J Med 1993;86:293-9.
21. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 1994;41:95-102.
22. Orme SM, McNally RJ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 1998;83:2730-4.
23. Holdaway IM, Rajasoorya RC, Gamble GD. Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 2004;89:667-4.
24. Thorner MO. Acromegaly and serum insulin like growth factor 1. Horm Res 2004;62(suppl.1):34-6.
25. Paisley AN, Trainer PJ. The challenges of reliance in insulin-like growth factor I in monitoring disease activity in patients with acromegaly. Horm Res 2004;62(suppl.1):83-8.
26. Milani D, Carmichael JD, Welkowitz J, Ferris S, Reitz RE, Danoff A, et al. Variability and reliability of single serum IGF-1 measurements: Impact on determining predictability of risk ratios in disease development. J Clin Endocrinol Metab 2004;89:2271-4.
27. Mukherjee A, Monson JP, Jonsson PJ, Trainer PJ, Shalet SM, KIMS Internation Board. Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders. J Clin Endocrinol Metab 2003;88:5865-70.
28. Melmed S, Kleinberg D. Anterior pituitary. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS. Williams textbook of endocrinology. 10th edition. Philadelphia: Elsevier Science, 2003. pp. 230-42.
29. Holdaway IM. Treatment of acromegaly. Horm Res 2004;62:79-92.